Piloting the effectiveness of pig health education in combination with oxfendazole treatment on prevention and/or control of porcine cysticercosis,gastrointestinal parasites,African swine fever and ectoparasites in Angónia District,Mozambique

A community-based intervention combining health education (HE) and treatment of pigs for control of porcine cysticercosis (PC), gastrointestinal (GI) helminths, African swine fever (ASF) and external parasites was tested involving six villages of resource-poor smallholder pig farmers. Farmers and pigs of six rural villages were randomly allocated into group 1 (HE), which served as controls, and group 2 (HE?+?OFZ) pigs received a single oral dose of 30 mg/kg OFZ. Farmers were trained in pig health, housing and feeding. The proportion of farmers with confined pigs, the adoption rate of the introduced pig pen, the sero-prevalence of PC and ASF, the prevalence and intensity of GI nematodes and the prevalence of ectoparasites were measured at 9, 15 and 24 months after initiation and compared to a baseline survey to seek the effectiveness of the interventions. There was no clear effect of the intervention on the sero-prevalence of PC, but analysis of the rate of change in prevalence between the two groups showed significant effect with the rate of change to lower prevalence in the HE?+?OFZ group compared to the HE group. Although HE managed to improve the farmer’s knowledge in the control and prevention of ASF and ectoparasites, there was no significant reduction in the sero-prevalence of ASF and the prevalence of ectoparasites throughout the two-year period. The reported ineffectiveness of the intervention in this study suggested that more research is needed to develop more effective methods for controlling PC, ASF and pig parasites.     

Comparative immune response and pathogenicity of the H9N2 avian influenza virus after administration of Immulant®, based on Echinacea and Nigella sativa,in stressed chickens

Avian influenza vaccines are commonly used in the poultry industry, and some medicinal plants can increase the efficacy of such vaccines. The objective of this study was to evaluate the effect of Immulant^® (IMU) (a commercial product based on Echinacea and Nigella sativa) on stress induced by dexamethasone (DEX) in chickens vaccinated (VAC) against the H9N2 avian influenza virus (AIV-H9N2). Seven experimental groups were included: the negative control, VAC, DEX, VAC + DEX, VAC + DEX + IMU, VAC + IMU and IMU groups. The vaccinated chickens (at 10 days of age) were injected daily with DEX for three days pre-vaccination and for three days pre-challenge and orally administered 1% IMU for 6 weeks post-vaccination (PV). The chickens were then challenged intranasally with AIV-H9N2 at 28 days PV. Serum, blood, tracheal and cloacal swabs and tissue samples were collected in the 1^st and 4^th weeks PV and at different time points post-challenge. The results showed significant changes (P ≤ 0.05) in oxidative stress and antioxidant biomarkers (malondialdehyde, nitric oxide and reduced glutathione), haematological and immunological parameters, final live weights, relative organ weights and histopathological lesions between the VAC+DEX group and the VAC group. Moreover, IMU significantly increased protection rates post-challenge, HI antibody titers and heterophil phagocytic activity and decreased DEX-induced stress and virus shedding titers. In conclusion, oral administration of 1% IMU for six weeks can enhance the immune response after AI-H9N2 vaccination and reduce the pathogenicity of infection in stressed chickens.     

Studies on the toxic effects of crambe meal and two of its constituents, 1‐cyano‐2‐hydroxy‐3‐butene (GHB) and epiprogoitrin,in broiler chick diets

1. Studies were undertaken to determine a safe inclusion rate for crambe (Crambe abyssinica) meal in broiler chick diets, and to determine the mechanism for adverse effects by investigating its constituents; l‐cyano‐2‐hydroxy‐3‐butene (CHB) and 3‐butenyl glucosinolate (epi‐progoitrin, E‐PG).

2. Crambe meals were prepared to differ in E‐PG (19, 36 and 40 g/kg) and CHB contents (0.1, 0.7 and 1.9 g/kg), and with either active or inactive thioglucosidase.

3. Meals were fed to 7‐d‐old broiler chicks at 50 or 100 g/kg of the diet for 12 or 13 d. In separate studies, isolated E‐PG or CHB were mixed into the diet or administered by gavage to 7‐d‐old broiler chicks in amounts equivalent to 50 or 100 g/kg crambe meal diets for 10 and 12 d, respectively.

4. Weight gain decreased (P<0.05) in chicks fed on the high glucosinolate crambe diets or isolated E‐PG. Food consumption decreased (P<0.05) in chicks fed on the diet containing the high E‐PG meal with active enzyme.

5. Mild liver lesions and increased serum aspartate aminotransferase were found in chicks fed on the diet containing the high glucosinolate meal with active enzyme. Other organs, including thyroids, were normal.

6. Commercially‐processed crambe meal appeared safe at an inclusion rate of 50 or 100 g/kg diet, but could not be recommended at this point for long term feeding.     

Effect of supplementation with n-3 polyunsaturated fatty acids and/or β-glucans on performance,feeding behaviour and immune status of Holstein Friesian bull calves during the pre-and post-weaning periods

Background: Previous research in both calves and other species has suggested n-3 polyunsaturated fatty acids(PUFA) and β-glucans may have positive effects on immune function. This experiment measured performance,behaviour, metabolite and immunological responses to pre-weaning supplementation of dairy bull calves with n-3 PUFA in the form of fish oil and β-glucans derived from seaweed extract. 44 Holstein Friesian bull calves, aged 13.7± 2.5 d and weighing 48.0 ± 5.8 kg were artificially reared using an electronic feeding system. Each calf was offered5 L(120 g/L) per day of milk replacer(MR) and assigned to one of four treatments included in the MR,(1) Control(CON);(2) 40 g n-3 PUFA per day(FO);(3) 1 g β-glucans per day(GL) and(4) 40 g n-3 PUFA per day 1 g/d β-glucans(FOGL) in a 2 × 2 factorial design. Milk replacer and concentrate was offered from d 0–62(pre-weaning),while concentrate provision continued for a further 31 d post-weaning period. Individual daily feed intake and feeding behaviour was recorded throughout, while bodyweight and blood analyte data were collected at regular intervals.Results: Overall mean concentrate DMI from d 0–93 was 1.39, 1.27, 1.00 and 0.72 kg/d for CON, FO, GL and FOGL calves, respectively(SEM = 0.037; P 0.0001). Calves supplemented with GL were significantly lighter(P 0.0001) at both weaning(d 62) and turnout to pasture(d 93) than un-supplemented calves, with a similar effect(P 0.0001)evident for calves receiving FO compared to un-supplemented contemporaries. Supplementation with GL reduced the number of unrewarded visits where milk was not consumed(P 0.0001) while supplementation with FO increased mean drinking speed(P 0.0001). Supplementation with GL resulted in greater concentrations of haptoglobin(P = 0.034), greater serum osmolality(P = 0.021) and lower lymphocyte levels(P = 0.027). In addition,cells from GL supplemented calves exhibited a lower response than un-supplemented contemporaries to both Phytohaemagglutinin A stimulated IFN-γ(P = 0.019) and Concanavalin A stimulated IFN-γ(P = 0.012) following in vitro challenges.Conclusions: Pre-weaning supplementation of bull calves with either n-3 PUFA or β-glucan resulted in reduced voluntary feed intake of concentrate and consequently poorer pre-weaning calf performance. There was no evidence for any beneficial effect of either supplementation strategy on calves' immune responses.